Non-Invasive Blood Glucose Monitoring System Market Size, Share, and Trends 2024 to 2034

Non-Invasive Blood Glucose Monitoring System Market Size and Companies

The global non-invasive blood glucose monitoring system market size was USD 26.97 million in 2023, accounted for USD 33.07 million in 2024, and is expected to reach around USD 253.69 million by 2034, expanding at a CAGR of 22.6% from 2024 to 2034. The North America non-invasive blood glucose monitoring system market size reached USD 14.29 million in 2023. 

Non-Invasive Blood Glucose Monitoring System Market Key Takeaways

• Based on technology, the spectroscopy segment has captured the highest revenue share in 2023.
• Based on end users, the home care segment held the highest market share in 2023.
• Based on modality, the segment of non-wearable maintained a dominating status in the market.
• Based on modality the segment of the wearable is emerging at a faster rate and it's foreseen to become a larger market from 2024 to 2034.
• Based on distribution channels, the retail sales segment has emerged as a dominant market.
• Based on geography, The North America region accounted for the highest revenue share in 2023.

U.S. Non-Invasive Blood Glucose Monitoring System Market Size and Growth 2024 to 2034

The U.S. non-invasive blood glucose monitoring system market size was estimated at USD 10.03 million in 2023 and is predicted to be worth around USD 96.32 million by 2034, at a CAGR of 22.8% from 2024 to 2034.

On the basis of geography, the huge number of people who are suffering from diabetes and non-invasive blood glucose disorders in the region of North America has proved to be a major factor that has made this region a dominant market and is foreseen to continue in a similar fashion during the future as well. As a result of the developed status of the country these sedentary lifestyle practices have increased to a great extent which results from the huge number of multinational companies would you demand long working hours. Hence the increasing amount of stress and lifestyle disorders have proved to be the causative factors for diabetes and other non-invasive blood glucose-related disorders. The demand for non-invasive blood glucose monitoring systems has seen a tremendous boost in this region which is supported by the high disposable income available to the people.

The next largest market which follows is the region of Europe which comprises a huge client base suffering from diabetes. The rapidly growing awareness regarding the management of diabetes among people has boosted the market size of non-invasive blood glucose monitoring systems. The region of Asia Pacific has emerged as the next sector which has shown considerable growth due to the increasing number of people suffering from diabetes and hence the demand and supply of non-invasive blood glucose monitoring systems have increased.

Market Overview

The rapidly increasing number of patients suffering from diabetes has increased the demand for efficient non-invasive blood glucose monitoring systems in the market. Huge investments are made by the key market players with a view to carrying out rapid research and development programs that will help them to introduce advanced machines and monitoring systems for diabetes. The outbreak of the pandemic had a considerable impact on the growth of the non-invasive blood glucose monitoring system as the COVID infection had a direct relation to the non-invasive blood glucose level of the individual. Many cases of diabetes emerged after the occurrence of the pandemic. The use of insulin was rapidly increased in the hospital sector with a view to controlling the sugar levels of the patients.

Non-Invasive Blood Glucose Monitoring System Market Growth Factors

The rapidly increasing number of complications in the body of the individual after the occurrence of diabetes has helped to boost the market for non-invasive blood glucose monitoring systems. Non-healing of wounds becomes a major complication that needs to be managed by evaluating the glucose levels in the body which has a direct impact on the healing process.  Key market players are making constant efforts to make these systems affordable for patients with a view to increasing the demand and supply all over the world.

• Increasing awareness among people
• The rapidly growing diabetic population
• Increasing demand for advanced technology

Market Scope

Market Dynamics

Key Market Drivers

• Constant monitoring - A continuous monitoring system helps to evaluate the condition of the patient constantly and can be reevaluated for selecting the suitable line of treatment and diet. An increase in the number of diabetes patients which is mostly due to a change in their lifestyles and other environmental factors Will drive the market growth in the coming years period obesity is another reason which leads to diabetes which will in turn increase the need for monitoring devices. The number of deaths that have occurred recently, especially in the United States will lead to the growth of the market during the forecast period. 
• Easy application - The process of operating these techniques is extremely easy and comfortable which attracts potential consumers. The availability of devices that are easy to use will also help in the growth of the market. Constant research and development in this field will lead to the introduction of better and more efficient devices in the coming years period as many new products are being launched in the market the users of these products can easily access their products. 

Key Market Challenges

• High cost of technology - The expensive devices which are used for the procedure prove to be a major challenge for the key market players. The lack of disposable income available to the people hampers the growth of the market considerably. The development cost of these devices is high and the reimbursement policy is offered in the market are not favorable due to which the market growth will be hampered in the coming years. The supply of these blood glucose monitoring systems is also affected to a great extent. When it comes to the nations like India and China the use of these devices has increased but the high cost of these devices will hamper the growth of the market in the coming years. An increase in the number of expenses made by the consumers for these devices will put a major strain on the consumers especially when it comes to developing nations. In underdeveloped nations, the high cost of these devices will reduce their penetration and prove to be a challenge to enter these markets. 

Key Market Opportunities

• Increasing demand for advanced technology - Increasing awareness regarding the available facilities and advanced technologies for monitoring non-invasive blood glucose and controlling it has helped the market of non-invasive blood glucose monitoring systems to show tremendous growth. As many market players are engaged in providing innovative products and the availability of advanced technologies for these products will lead to the growth of the market and provide good opportunities in the coming years.
• One of the leading technologies which are being used in this industry is electromagnetism. The availability of these devices in the form of wearable and non-wearable types will also provide good opportunities for the growth of this market. 

Technology Insights

On the basis of technology, the spectroscopy segment accounted highest revenue share in 2023. An increase in the number of cases of diabetes and the complications associated with this disease will lead to the growth of the market in the coming years. There are significant consequences of these diseases on the families as well as the individuals due to which the need for this technology is expected to grow in the coming years period as the non-invasive procedures are painless and quick the need for these devices is expected to grow well in the coming years period the availability of cost-effective solutions will also help in the growth of the market during the forecast period. 

End User Insights

On the basis of the end user, the home care segment held the highest market share in 2023. Increased use of mobile phones and connected devices will lead to the growth of this market.

Monitoring of the patients with the help of remote solutions and the availability of telehealth services will lead to the growth of this market during the forecast period. Increased use of the management devices which are available at the home will drive market growth. In order to treat diabetes consumers, have an increased preference for home care services. This inclination will drive market growth during the forecast period.

Modality Insights

On the basis of modality, the segment of non-wearable maintained a dominating status in the market pertaining to its huge demand among the people. The existence of key market players in this sector who have great potential along with huge economic backup has helped this segment to perform better than its counterparts in the market. This becomes the primary reason for the great support behind the growth of the market during the forecast period.

On the other hand, the segment of the wearable is emerging at a faster rate and it's foreseen to become a larger market during the future times to come resulting from its rapid development. The huge number of innovations and products that are being launched into the market by the key market players and manufacturers has helped the market to strengthen its foothold for the future times to come. Increasing awareness among the people regarding the pros and cons of the system it's helping the market to show tremendous results. 

Distribution Channel Insights

On the basis of distribution channels, the segment of retail sales has emerged as a dominant market due to the huge demand and supply chain which results from the existence of a huge number of people suffering from this disease. Usually, only in the initial stages of this disorder do people tend to visit a hospital sector and after that, they usually prefer to purchase the medicines according to the prescription given from the retail stores. This tendency of purchasing medicines over the counter from retail stores has proved to be a major factor that has boosted the economy for retail sales.

The regular demand and supply which is experienced in retail sales owing to the huge client base available in the market has supported the growth of this segment to a great extent and is foreseen to dominate the market during the future period as well.

The segment of institutional sales has presented a moderate pace in the market due to the lower rate of adoption of non-invasive blood glucose monitors in the hospital sector and clinics. After the outbreak of the pandemic, many healthcare sectors adopted these systems which included continuous glucose monitors on a larger scale, and hence it expects considerable growth in the years to come.

Recent Developments

• In February 2021 – Ascensia diabetes care holding AG acquired the distribution channel of Eversense XL, which is located in Germany, Spain, Italy, Netherlands, and Switzerland with a view to meet the increasing demands in the market of Europe.
• In March 2021 – F. Hoffmann- la Roche Co Introduced Accuchek instant product which connects directly to with mySugr app. This app provides the data for non-invasive blood glucose parameters in real-time. 

Non-Invasive Blood Glucose Monitoring System Market Companies

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd.
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Segments Covered in the Report

By Technology

• Spectroscopy 
• Electromagnetic 
• Microwave 
• Ultrasonic 
• Thermal 
• Others

By End User

• Hospitals
• Homecare
• Clinics

By Modality

• Non wearable
• Wearable
• Invasive
• Non-invasive

By Distribution Channel

• Retail sales
• Institutional sales

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)